Results 11 to 20 of about 173,185 (344)

Autoimmune Hepatitis [PDF]

open access: yesBest Practice & Research Clinical Gastroenterology, 2006
Autoimmune hepatitis (AIH) was the first chronic liver disease in which remission was achieved by immunosuppression. Prognosis is poor when left untreated. Since the original description in 1950 by Waldenström, the initially reported treatment option has remained until today and is the core of the basic therapeutic strategy of inducing remission with ...
Stefan, Lueth, Ansgar W, Lohse
  +9 more sources

Autoimmune Hepatitis [PDF]

open access: yesCurrent Pediatric Reviews, 2015
Autoimmune hepatitis (AIH) is a severe hepatopathy characterised by female preponderance, hypertransaminasaemia, elevated levels of immunoglobulin (IgG), presence of serum autoantibodies and, histologically, by interface hepatitis. AIH occurs both in adults and children, being particularly aggressive in the latter.
Longhi, Maria Serena   +2 more
openaire   +7 more sources

Autoimmune hepatitis [PDF]

open access: yesNew England Journal of Medicine, 1996
Autoimmune hepatitis is an inflammatory liver disease in which the immune system is believed to orchestrate an immune attack onto the liver cell. Current knowledge suggests that both T helper 1 (TH1) and TH2 programmes are involved in the generation of the liver damage.
Vergani, D, Mieli-Vergani, G
openaire   +13 more sources

Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis

open access: yesEinstein (São Paulo), 2023
Objective Published studies have shown associations between anti-ribosomal P (anti-P) antibody and systemic lupus erythematosus with hepatic manifestations. This has been reported also in autoimmune hepatitis.
Clarisse de Almeida Gallo   +6 more
doaj   +1 more source

New treatments/targets for primary biliary cholangitis

open access: yesJHEP Reports, 2019
Summary: Primary biliary cholangitis (PBC) is an autoimmune, cholestatic, chronic liver disease that ultimately progresses towards cirrhosis and liver failure if untreated.
Christophe Corpechot   +2 more
doaj   +1 more source

Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease

open access: yesFrontiers in Medicine, 2021
Background: The impact of the influenza A (H1N1) and SARS-CoV-2 virus on the development of autoimmune hepatitis has not been described previously.Methods: In this case series, we evaluated the dynamic changes in liver function of three patients with ...
Qian Li   +9 more
doaj   +1 more source

The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study [PDF]

open access: yes, 2013
Background Autoimmune Hepatitis is a chronic liver disease which affects young people and can result in liver failure leading to death or transplantation yet there is a lack of information on the incidence and prevalence of this disease and its natural ...
AD Yeoman   +17 more
core   +3 more sources

Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis [PDF]

open access: yes, 2017
Background The joint effect of the interaction of alcohol intake, hepatitis B virus (HBV) and hepatitis C virus (HCV) on the risk of cirrhosis is still unexplored because a large sample size is required for this investigation.
Almasio, Piero Luigi   +11 more
core   +5 more sources

Autoimmune hepatitis

open access: yesJournal of Hepatology, 2000
Autoimmune hepatitis (AIH) is a rare disease, characterized by female predominance, hypergammaglobulinemia, autoantibodies, association with HLA DR3 and HLA DR4 and a good response to immunosuppression. Different subtypes of AIH may be distinguished, based on differences in the autoantibody patterns.
P, Obermayer-Straub   +2 more
  +7 more sources

Hepatitis induced by noni juice from Morinda citrifolia: A rare cause of hepatotoxicity or the tip of the iceberg? [PDF]

open access: yes, 2006
A 24-year-old female patient presented to her community hospital with mild elevations of serum transaminase and bilirubin levels. Because of multiple sclerosis, she was treated with interferon beta-la for 6 weeks.
Diebold, J.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy